Related Experiment Video
Updated: Jun 23, 2026

Establishment of a Severe Dry Eye Model Using Complete Dacryoadenectomy in Rabbits
Published on: January 8, 2020
Iatrogenic eyelid granulomata
David Haider1, Robert Wynn, S Ahmed Sadiq
1Manchester Royal Eye Hospital, Manchester, UK. dhaider@nhs.net
Abstract:
The authors report a possible association between posaconazole, a new systemic antifungal, and eyelid granulomata. A 12-year-old boy presented with a 2-week history of bilateral eyelid granulomata. They were noted to reduce in size and symptoms when posaconazole was discontinued. Symptoms increased when the drug was restarted.
Insights
A new antifungal drug, posaconazole, may be linked to eyelid granulomata. Discontinuing the medication reduced symptoms, while restarting it caused them to worsen.
Area of Science:
- Ophthalmology
- Dermatology
- Infectious Diseases
Background:
- Posaconazole is a novel systemic antifungal agent.
- Eyelid granulomata are inflammatory lesions affecting the eyelids.
Observation:
- A pediatric patient presented with bilateral eyelid granulomata.
- The granulomata showed a temporal relationship with posaconazole use.
Findings:
- Discontinuation of posaconazole led to a reduction in granuloma size and symptoms.
- Resumption of posaconazole therapy resulted in an exacerbation of symptoms.
Implications:
- This case suggests a potential adverse effect of posaconazole.
- Further investigation is warranted to confirm the association between posaconazole and eyelid granulomata.
Related Concept Videos
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Accessory Structures of the Eye
Microbiome of the Eye
